Loading

Annals of Clinical Cytology and Pathology

Human papillomavirus Prevalence and Genotyping in Penile Squamous Cell Carcinoma Patients

Research Article | Open Access

  • 1. Tumors and DNA Bank of Maranhão, Federal University of Maranhão, Brazil
  • 2. Medicine III Department, Federal University of Maranhão, Brazil
  • 3. Department of Morphology, Federal University of Maranhão, Brazil
+ Show More - Show Less
Corresponding Authors
Flávia Castello Branco Vidal, Tumors and DNA Bank of Maranhão, Federal University of Maranhão, São Luís, Rua Coelho Neto, 311 Centro, CEP: 65020-140, Brazil, Tel: 55-98 21091273
Abstract

Objective: To evaluate the prevalence of human papillomavirus (HPV) infection in penile carcinomas in São Luís, Brazil, and to correlate the virus presence to histopathological factors.

Methods: This was a prospective analytical study of 29 patients submitted to parcial and total penectomy surgery. Data were collected through a survey and medical record analysis. Tumor samples were collected during surgeries and DNA extraction was performed. PCR-Nested technique was used for viral DNA amplification, with PGMY09/11 and GP+5/+6 primers. Automated sequencing analyses were made in order to genotype the HPV types.

Results: The mean age of the patients was 63.2 ± 17.3. Population consisted of a low educated and low socioeconomic status man (82.8%), illiterate (55.2%). Most of the men (62.1%) had not been circumcised, had never used a condom (72.4%), and 51.7% reported the occurrence of some previous sexually transmitted disease (STD). The most prevalent type of lesion was ulcerative (51.7%) and the glans was affected in 93.1% of the cases. HPV presence was detected in 72.4% of the cases and the oncogenic risk HPV 16 was the most prevalent (55.6%). Statistical difference was observed in the correlation between HPV status and previous STD (p = 0.03).

Conclusion: Various risk factors for penile cancer were observed like absence of circumcision, no use of condom and high prevalence of HPV. The high prevalence of HPV and high-risk types suggest the need for further action to prevent the spread of HPV among the population.

Citation

Barros Ramos WL, Almeida Cunha AP, de Lima Costa LH, Branco Vidal JPC, Rodrigues VP, et al. (2020) Human papillomavirus Prevalence and Genotyping in Penile Squamous Cell Carcinoma Patients. Ann Clin Cytol Pathol 6(1): 1135.

Keywords

• Penile cancer
• Papillomavirus infections
• Genotyping
• Association
• Men’s health

INTRODUCTION

Penile cancer is a rare disease with 26 000 new cases occurring worldwide annually [1]. In Western Europe, represents 0.3 to 0.6% of malignant tumors, while in Africa incidence reaches 10% of all malignant cancers affecting men. In Brazil, penile cancer represents 2% of the total, with the highest prevalence being observed in the North and Northeast regions [2].

Human Papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide [3]. Studies show that 30% of the world’s sexually active population is infected with HPV, and about 500,000 new cases are detected per year, with 70% being found in developing countries [2]. This virus has been recognized as one of the possible causes of penile carcinoma, but its role in the development of the disease and its correlation with the prognosis, remain unclear [4,5]. Besides HPV infection, known risk factors for the development of penile cancer include poor hygiene, phimosis, smoking, low socioeconomic status, a history of genital warts and/or other sexually transmitted diseases and risky sexual behavior [4].

A recent study pointed out that the state of Maranhão has the highest incidence of penile cancer in Brazil and globally [2]. The aim of the present study was to describe socioeconomic variables, sexual behavior, clinical and histopathological aspects of penile epidermoid carcinoma patients from Maranhão state, Brazil. We also performed HPV genotyping as it is an important epidemiological data for evaluating the efficacy of screening programs and campaigns, recently extended to the male population in Brazil. Statistical analysis was performed to detect a possible association between the variables and HPV presence.

MATERIALS AND METHODS

Patients

A prospective cross-sectional study was carried out between the years 2015 and 2017 in a cancer reference hospital in the State of Maranhão, Brazil. A convenience sample of twenty-nine patients who submitted to partial or total penectomy surgery participated in the study. A survey was conducted with these patients to collect sociodemographic and personal history data. Clinical and histopathological data were collected from medical records.

In accordance with the provisions of the Declaration of Helsinki for research involving human, the study was approved by the Committee of Ethics and Research of the Federal University of Maranhão. Informed consent was obtained from all individual participants included in the study.

HPV detection

During the surgical procedure, fragments of tumor tissue were collected and sent to the Tumors and DNA Bank of Maranhão laboratory. The DNA of the samples was extracted through the Dneasy Blood and Tissue kit (QIAGEN Ltd, UK). PCR-Nested technique was used for viral DNA amplification, with PGMY09/11 primers in the first round, and with GP+5/+6 primers in the second round. Visualization of the amplified products was performed using 1.5% agarose gel electrophoresis. DNA-HPV positive samples were submitted to automated sequencing in a 3500 Series Genetic Analyzer (ThermoFisher, MA, USA), performed with the ET Dye Terminator Cycle Sequencing kit (GE Healthcare, UK) according to the manufacturer’s suggested protocol.

Statistical analysis

The dependent variable was represented by HPV detection (absence or presence), while the independent variables included age, socioeconomic characterization, behaviors, hygiene habits, clinical and histopathological parameters.

The descriptive statistics of the data were initially performed using measures of frequency, mean and standard deviation. The chi-square or Fisher’s exact test was used to compare the distribution of categorical variables between groups with absence or presence of HPV. The Spearman coefficient (Rs) was used to analyze the correlation between the ordinal grading variables of the neoplastic lesion (Jackson, Broders and Component T of the TNM scale). The level of significance was 5% (p ≤ 0.05). Statistical analysis was performed with the SPSS program (version 17.0, IBM, Chicago, IL, USA). The level of significance was 5% (p ≤ 0.05).

RESULTS

Table 1 describes socioeconomic variables and life style behavior of patients with penile epidermoid carcinoma in São Luís, Brazil, and its relationship between HPV detection. The total subjects in this study were 29 with the mean age of 63.2 ± 17.3. Most of the patients were over 60 years of age (69%) (Table 1). The older patient was 97 and the younger was 23 year old. The studied population consisted of a low educated and low socioeconomic status man with an income of up to 1 minimum Brazilian wage (82.8%) (less than $260 dollars), were illiterate (55.2%), 62.1% was brown color, and 79.3% lived in municipalities in the interior of Maranhão. Also in Table 1, 69% of the patients were in a consensual relation, 62% of the patients were smokers or former smokers and 62.1% were drinkers or former drinkers. There were no association between HPV presence and the socioeconomic and life style behavior variables.

Table 2 displays the distribution of variables related to sexual behavior. As shown, 62.1% patients had not been circumcised, 72.4% had never used a condom, and 51.7% reported the occurrence of some previous sexually transmitted disease (STD). The majority of patients (55.1%) reported performing genital hygiene. Thirteen patients (44.9%) reported that their first sexual relation was before 18 years and 62.1% declare ten or more sexual partners during life. Statistical difference was observed in the correlation between HPV status and previous STD (p = 0.03). Patients who reported previous STD were more likely to have HPV.

Table 3 shows penile lesions localization. Most patients (51.7%) exhibited more than one affected region, with the glans involved in 93.1% of the patients. HPV presence was not correlated with lesion localization or number of affected sites.

All tumors histological subtype was epidermoid carcinoma. Table 4 shows a higher frequency of the ulcerated lesion type (41.4%). Most of the tumors had no perineural (96,6%) or angiolinfatic invasion (86,2%). The well differentiated tumors (grade I) identified in this work, according to Broder’s classification, were the most prevalent (41,4%). According to staging of Jackson most tumors were stage I and II (27.6%). TNM staging demonstrated a prevalence of T1 lesion (27.7%). HPV presence was not correlated with any of the clinical and histopathological variables.

The presence of HPV was confirmed in 21 (72.4%) patients out of the 29 patients comprising the sample. Furthermore, viral types were identified in 45% of the patients through the automated sequencing technique. Type 16, considered to be a high oncogenic risk, was found in 55.6% of the patients, followed by types 45 (11.1%), 6 (11.1%), 52 (11.1%), and 33 (11.1%).

DISCUSSION

Our results reveal that 69% of the penile cancer patients were older than 60 years. This is consistent with previous studies showing that penile cancer incidence is higher in men in the sixth decade of life [3]. Comparable results have been found in studies by Favorito [6], Hernandez [7], Chaux [8], Sousa [9] and Chalya [10]. In contrast, in a single study by Slaoui [11] a mean age for the incidence of penile cancer was reported as below 60 years of age.

In this study, 79.3% of the patients lived in municipalities in the interior of Maranhão. This observation supports the study of Chaux [8] who identified a high incidence (83%) of men with penile cancer residing outside the major centers. The results can be explained due to the delay in seeking of medical care from men living outside the major centers, because of the greater difficulty in accessing health services. Educational levels, family income, and marital status were also evaluated in the socio-demographic survey. A prevalence of illiterate men with a family income of up to one minimum wage was observed. Again, this is consistent with previous studies, showing that neoplasia affects mainly men from lower socio-economic classes and with a lower level of education [7,11-13]. Hernandez [7], reported a higher penile cancer incidence in municipalities where less than 75% of the population completed high school, in comparison with patients living in communities with higher education levels. Torbrand [14] suggested that a low educational level is associated with an increased risk of developing invasive penile cancer.

Regarding life style behavior, most patients in this study (62%) reported using tobacco and 62.1 referred alcohol using at some point in their lives. Daling [15] demonstrated the relationship between tobacco use and the risk of developing penile cancer, where active smokers and former smokers showed, respectively, a probability 2.3 and 1.9 times higher of developing cancer. A 1.5 times higher risk of in situ penile cancer development and a 4.5 times higher risk of invasive cancer development was observed among current smokers in that same study. Wanick [16] showed that tobacco use was observed in 75% of cases of invasive penile cancer. A high incidence was also found in the work of Chaux [8] (76%) and Koifman [12] (56.5%) of the patients diagnosed with penile cancer reported the use of tobacco. The use of alcohol and/ or other drugs can lead to a promiscuous sexual behavior witch can increase the chance of HPV infection and is also associated with increased risk of penile cancer [8].

In our study, it was observed that 62.1% of the patients had not been circumcised. In a study by Koifman [12] performed in Brazil, the absence of circumcision was also common. The presence of phimosis and exuberant prepuce make it difficult to expose the glans and conduct adequate cleansing of the genital region, thus influencing the development of penile cancer [8]. The incidence of penile cancer in countries with higher levels of neonatal circumcision, such as Israel, is extremely low and may reach rates below 1% [13]. A systematic review analyzing the effect of circumcision on penile cancer confirmed its beneficial effect when performed before 18 years of age compared to an increased risk of developing such cancer when carried out during adulthood [17].

A worrying result of our study was the high prevalence (72.4%) of patients who had never used a condom and admitted previous sexually transmitted infection (51.7%). The majority also has their first coitus before 18 years old and had more than 10 sexual partners during life. These data represents a promiscuous sexual behavior of patients that may increase the chance of HPV infection and other etiological conditions that favors penile cancer [18]. Other studies also reported increased promiscuous sexual behaviour and history of sexually transmitted infections among penile cancer patients [4,8].

Statistical analysis showed a significant (p = 0.03) relation between previous reported STD and HPV presence. A common risk factor for penile cancer includes a clinical history of sexually transmitted diseases such as gonorrhea, Chlamydia, and/or syphilis [6]. It is know that some sexually transmitted infectious agents, such as Chlamydia trachomatis and Herpes simplex, cause local inflammation, and could contribute to HPV infection and cervical lesion progression [19,20]. The relation between STDs agents and HPV coinfection in penile cancer progression is unknown.

With respect to the predominant location of the penile lesion, 51.7% of the cases showed more than one affected region, with the glans being identified in 93.1% of the patients. This result supports a study by Wanick [16], where the predominant localization of penile cancer (55.5%) was found to be the glans alone, and, in association with other regions of the penis, comprised 91.1% of the cases.

All patients were diagnosed with squamous cell carcinoma. Ulcerative and warty tumors were prevalent in our study (65%) and were associated with HPV infection. Well differentiated tumors (grade I), according to Broders´classification, were the most prevalent among the tumors that could be classified. In a Brazilian study, Fonseca [21] also identified a greater number of cases classified as well differentiated (grade I). Jackson staging demonstrated an equal prevalence between stage I and II lesion.

Regarding the detection of HPV DNA, the presence of HPV was detected in 72.4% of the patients with penile cancer. The overall prevalence in a study by Calmon [22] on patients from the States of Pará and São Paulo, was 48.9% for some type of HPV. Backes [23] found a 48% prevalence of HPV in 1266 cases from 30 studies of invasive penile cancer. Chaux [8] found HPV DNA in 36% of the analyzed samples. Therefore, a great variation of the incidence of HPV can be observed in studies involving penile cancer, ranging between 15% and 77.5%. This variation can be explained through the methodology used in the detection of HPV, the nature of the studied population, and the conservation of the samples [24]. The PCR technique that we performed, using PGMY 09/11 and GP5+/6+ primers, has been widely used in epidemiological studies of HPV, due to its high specificity and sensitivity [2].

HPV 16 was detected in 55.6% of the patients through automated sequencing, followed with subtypes 6, 33, 45, and 52, with a prevalence of 11.1%. Cubilla [25] found HPV 16 in 72%, followed with subtype 6, in 9% of cases. In a study conducted by Scheiner [26] in Rio de Janeiro, Brazil, subtype 16 was also the most prevalent (52%). Alemany [27] also found a higher incidence of subtype 16. In Brazil, high-risk HPVs account for 25% to 56% of cancer cases. All of the HPV types founded in our study can be preventable by the nonavalent vaccine (GARDASIL®9, Merck) which prevents against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. However, in Brazil, the public health system offers the quadrivalent Gardasil (prevent types 6, 11, 16 and 18). So, to improve prevention against penile, cervical, vulvar, vaginal, and anal cancers, all caused among other things by HPV, the Brazilian authorities should think in the implementation of nonavalent vaccine.

As shown in Table 3 and 4 no statistically significant difference was observed (p < 0.05) between the variables evaluated and the presence of HPV. The same was the case in the research by Sousa [9] Scheiner [26], Do [28] and Fonseca [29]. It seems that HPV infections are associated with the development of penile cancer; however, the role of viruses is not associated with the gravity of the disease.

Table 1: Relation between HPV detection, socioeconomic variables, and life style behavior of 29 patients with penile epidermoid carcinoma in São Luís, Brazil.

Variables Tota HPV p value
Absent Present
n (%) n (%) n (%)
Age group       0.37
< 60 years 9 (31) 1 (11.1) 8 (88.9)  
≥ 60 years 20 (69) 7 (30.0) 13 (70.0)  
Income       1.00
> 1 minimum wage 7 (17.2) 2 (28.6) 5 (71.4)  
≤ 1 minimum wage 22 (82.8) 6 (27.3) 16 (72.7)  
Education       0.99
Illiterate 16 (55.2) 5 (31.2) 11 (68.8)  
≤ 8 years of schooling 11 (34.5) 3 (27.3) 8 (72.7)  
> 8 years of schooling 2 (10.3) 0 (0) 2 (100)  
Race       0.99
White 5 (17.2) 1 (20) 4 (80)  
Brown 18 (62.1) 5 (27.8) 13 (72.2)  
Black 6 (20.7) 2 (33.3) 4 (66.7)  
Place of residence       0.64
Capital 6 (20.7) 1 (16.7) 5 (83.3)  
Interior 23 (79.3) 7 (30.4) 16 (69.6)  
Relationship       0.30
Single 3 (10.3) 0 (0) 3 (100)  
Consensual union 20 (69) 4 (20) 16 (80)  
Divorced 2 (6.9) 1 (50) 1 (50)  
Widow 2 (6.9) 1 (50) 1 (50)  
Not informed 2 (6.9) - -  
Smoking       0.64
No 11 (38.0) 2 (18.2) 9 (81.8)  
Former smoker 13 (44.8) 4 (30.8) 9 (69.2)  
Current smoker 5 (17.2) 2 (40) 3 (60)  
Drinking       0.68
No 9 (31) 2 (33.3) 6 (66.7)  
Former drinker 14 (48.3) 4 (28.6) 10 (71.4)  
Current drinker 4 (13.8) 0 (0) 4 (100)  
Not informed 2 (6.9) - -  
Probability value calculated using Fisher's exact test. *Statistically significant differences (P < 0.05).

Table 2: Relation between HPV detection and variables related to sexual behavior of 29 patients with penile epidermoid carcinoma in São Luís, Brazil.

Variables Total HPV P value
Absent Present
n (%) n (%) n (%)
Circumcision       1.00
No 18 (62.1) 4 (27.8) 14 (72.2)  
Yes 3 (10.3) 1 (0) 2 (100)  
No information 8 (27.6) - -  
Condom use       0.09
Always 1 (3.5) 0 (0) 1 (100)  
Sometimes 7 (24.1) 0 (0) 7 (100)  
Never 21 (72.4) 8 (38.1) 13 (61.9)  
Previous STD and/or genital warts       0.03*
No 8 (27.6) 4 (50) 4 (50)  
Yes 15 (51.7) 1 (3.4) 14 (93.3 )  
No information 6 (20.7) - -  
Genital hygiene       0.27
No 7 (24.1) 3 (42.9) 4 (57.1)  
Yes 16 (55.1) 2 (12.5) 14 (87.5)  
No information 6 (20.7) - -  
Age of first coitus       0.10
< 18 years 13 (44.9) 1 (7.7) 12 (92.3)  
≥ 18 years 7 (24.1) 3 (42.9) 4 (57.1)  
No information 9 (31) - -  
Number of sexual partners during life       0.62
< 10 8 (27.6) 1 (12.5) 7 (87.5)  
≥ 10 18 (62.1) 5 (27.8) 13 (72.2)  
No information 3 (10.3) - -  
Probability value calculated using Fisher's exact test. *Significant differences (P < 0.05).

Table 3: Relationship between HPV detection and penile lesion clinical variables of 29 patients with penile epidermoid carcinoma in São Luís, Brazil.

Variables Total HPV P value
Absent Present
n (%) n (%) n (%)
Lesion area        
Glans       0,467
Yes 27 (93,1) 9 (33,3) 18 (66,7%)  
No 2 (6,9) 0 (0) 2 (100)  
Foreskin       0,335
Yes 13 (44,8) 3 (23,1) 10 (76,9)  
No 16 (55,2) 6 (37,5) 10 (62,5)  
Corpus       0,081
Yes 6 (20,7) 0 (0) 6 (100)  
No 23 (79,3) 9 (39,1) 14 (60,9)  
Number of affected regions       0.449
One 14 (48,3) 5 (35,7) 9 (64,3)  
More than one 15 (51,7) 4 (26,7) 11 (73,3)  
Probability value calculated using Fisher's exact test. *Statistically significant differences (P < 0.05).

Table 4: Relationship between HPV detection and histopathological lesion variables of 29 patients with penile epidermoid carcinoma in São Luís, Brazil.

Variables Total HPV P value
Absent Present
n (%) n (%) n (%)
Ulcerated lesion       0.323
Absent 9 (31.0) 2 (22.2) 7 (77.8)  
Present 12 (41.4) 5 (41.7) 7 (58.3)  
No information 8 (27.6) - -  
Wart lesion       0.592
Absent 17 (58.6) 6 (35.3) 11 (64.7)  
Present 4 (13.8) 1 (25.0) 3 (75.0)  
No information 8 (27.6) - -  
Perineural invasion       0,689
Absent 28 (96,6) 9 (32,1) 19 (67,9)  
Present 1 (3,4) 0 (0) 1 (100)  
Angiolinfatic invasion       0,364
Absent 25 (86,2) 7 (28,0) 18 (72,0)  
Present 4 (13,8) 2 (50,0) 2 (50,0)  
Broders’ Classification       0,073
Grade I 12 (41,4) 6 (50,0) 6 (50,0)  
Grade II 7 (24,1) 0 (0) 7 (100)  
Grade III 4 (13,8) 2 (50,0) 2 (50,0)  
No information 6 (20,7) - -  
TNM staging       1,000
T1 8 (27,7) 2 (25,0) 6 (75,0)  
T2 7 (24,1) 2 (28,6) 5 (71,4)  
T3 5 (17,2) 2 (40,0) 3 (60,0)  
No information 9 (31,0)      
Staging of Jackson 1966       0,161
Stage I 8 (27,6) 2 (25,0) 6 (75,0)  
Stage II 8 (27,6) 2 (25,0) 6 (75,0)  
Stage III 2 (6,9) 2 (100) 0 (0)  
No information 11 (37,9) - -  
Probability value calculated using Fisher's exact test. *Statistically significant differences (P < 0.05).

 

CONCLUSION

HPV DNA was found in 72.4% of our patients. The high-risk type HPV 16 was observed in 55.6% of the lesions. The average age of the patients in the study was 63.2 years old. According to sociodemographic data, penile cancer patients consisted of a low educated and low socioeconomic status man, illiterate, were brown color and lived in municipalities in the interior of Maranhão. They were not circumcised and had never used condom. Prevalent lesions were in the glans region, in general ulcerated, and with Broder’s grade I (well differentiated). The clinical and histopathological variables did not tend to have an association with infection by the HPV virus.

ACKNOWLEDGEMENTS

We would like to express our grateful to Aldenora Bello Cancer Hospital and Hospital Geral Tarquinio Lopes Filho staff for allowing access to patients and the collection of samples and data. We also thank the government of Maranhão for the resources of this research through the grant (00460/15) from the Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Estado do Maranhão (FAPEMA).

REFERENCES

1. Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141: 664-670.

2. Coelho RWP, Pinho JD, Moreno JS, Garbis DVEO, do Nascimento AMT, Larges JS, et al. Penile cancer in Maranhão, Northeast Brazil: the highest incidence globally? BMC Urol. 2018; 18: 50.

3. Albero G, Villa LL, Lazcano-Ponce E, Fulp W, Papenfuss MR, Nyitray AG, et al. Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study. BMC Cancer. 2013; 13: 1-10.

4. Romero FR, Romero AW, Almeida RM, Oliveira FC Jr, Filho RT Jr. Prevalence and risk factors for penile lesions / anomalies in a cohort of Brazilian men ≥ 40 years of age. International Braz J Urol. 2013; 39: 55-62.

5. Silva R, Silva A, Nascimento S, Oliveira C, Bonfim C. Demographic and epidemiological aspects of penis cancer mortality. Acta Paulista de Enfermagem. 2014; 27: 44-47.

6. Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJ, Glina S. Epidemiologic Study on Penile Cancer in Brazil. International Braz J Urol. 2008; 34: 587-593.

7. Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008; 14: 888-894.

8. Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, et al. Epidemiologic Profile, Sexual History, Pathologic Features, and Human Papillomavirus Status of 103 Patients with Penile Carcinoma. World J Urol. 2013; 31: 861-867.

9. de Sousa ID, Vidal FC, Branco Vidal JP, de Mello GC, do Desterro Soares Brandão Nascimento M, Brito LM. Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects. BMC Urol. 2015; 15: 13.

10. Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients. World J Surg Oncol. 2015; 13: 71.

11. Slaoui A, Jabbour Y, El Ghazoui A, Karmouni T, Elkhader K, Koutani A, et al. Penile cancer: about ten cases at the University Hospital of Rabat, review of the literature. Pan Afr Med J. 2015; 22: 53.

12. Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: Evaluation of 230 cases. International Braz J Urol. 2011; 37: 231-240

13. Souza K, Reis P, Gomes I, Carvalho E. Estratégias de prevenção para câncer de testículo e pênis: revisão integrativa. Rev Esc Enferm USP. 2011; 45: 277-282.

14. Torbrand C, Wigertz A, Drevin L, Folkvaljon Y, Lambe M, Håkansson U, et al. Socioeconomic factors and penile cancer risk and mortality?; a population-based study. BJU Int. 2017; 119: 254-260.

15. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2011; 116: 606-616.

16. Wanick F, Teichner T, Silva R, Magnanini M, Azevedo L. Squamous cell carcinoma of the penis: clinicopathologic study of 34 cases. An Bras Dermatol. 2011; 86: 1082-1091.

17. Larke N, Thomas S, dos Santos Silva I, Weiss HA. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control. 2011; 22: 1097-1110.

18. Júnior PFM, Silva EHV, Moura KL, de Aquino YF, Weller M. Increased Risk of Penile Cancer among Men Working in Agriculture. Asian Pac J Cancer Prev. 2018; 19: 237-241.

19. Amorim AT, Marques LM, Campos GB, Lobão TN, de Souza Lino V, Cintra RC, et al. Co-infection of sexually transmitted pathogens and Human Papillomavirus in cervical samples of women of Brazil. BMC Infect Dis. 2017; 17: 769.

20. Wohlmeister D, Vianna DR, Helfer VE, Gimenes F, Consolaro ME, Barcellos RB, et al. Association of human papillomavirus and Chlamydia trachomatis with intraepithelial alterations in cervix samples. Mem Inst Oswaldo Cruz. 2016; 111: 106-113.

21. Fonseca AG, Pinto JASA, Marques MC, Drosdoski FS, Neto LORF. Estudo epidemiológico do câncer de pênis no Estado do Pará. Brasil Revista Pan-Amazônica de Saúde. 2010; 1: 85-90.

22. Calmon MF, Mota MT, Babeto É, Candido NM, Girol AP, Mendiburu CF, et al. Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs. PLoS One. 2013; 8: e53260

23. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009; 20: 449-457.

24. Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One. 2011; 6: 2-8.

25. Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive squamous cell carcinoma of the penis: a study of 202 cases from Paraguay. Am J Surg Patho. 2010; 34: 104-114.

26. Scheiner MA, Campos MM, Ornellas AA, Chin EW, Ornellas MH, Andrada-Serpa MJ. Human Papillomavirus and Penile Cancers in Rio de Janeiro, Brazil: HPV Typing and Clinical Features. Int Braz J Urol. 2008; 34: 467-476.

27. Alemany L, Cubilla A, Halec G, Kasamatsu E, Quirós B4, Masferrer E, et al. Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol. 2016; 69: 953-961.

28. Do HT, Koriyama C, Khan NA, Higashi M, Kato T, Le NT, et al. The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. Br J Cancer. 2013; 108: 229-233.

29. Fonseca AG, Soares FA, Burbano RR, Silvestre RV, Pinto LO. Human Papilloma Virus: prevalence, distribution and predictive value to lymphatic metastasis in penile carcinoma. Int Braz J Urol. 2013; 39: 542-550.

Received : 17 Apr 2020
Accepted : 28 Apr 2020
Published : 29 Apr 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X